NutraLife Biosciences Net Profit Margin 2013-2022 | NLBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

NutraLife Biosciences net profit margin from 2013 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

NutraLife Biosciences net profit margin from 2013 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$232B
Amgen (AMGN)	$157.3B
Gilead Sciences (GILD)	$131.2B
Vertex Pharmaceuticals (VRTX)	$118.7B
Bristol Myers Squibb (BMY)	$110.5B
CSL (CSLLY)	$80B
GSK (GSK)	$75.9B
Regeneron Pharmaceuticals (REGN)	$74.3B
Argenex SE (ARGX)	$38.8B
Alnylam Pharmaceuticals (ALNY)	$32.4B
BioNTech SE (BNTX)	$29.4B
BeiGene (ONC)	$23.3B
Biogen (BIIB)	$20B
Illumina (ILMN)	$16B
Insmed (INSM)	$14.6B
Genmab (GMAB)	$14.4B
Genmab (GNMSF)	$14.3B
Incyte (INCY)	$13.8B
Moderna (MRNA)	$13.8B
Intra-Cellular Therapies (ITCI)	$13.6B
BioMarin Pharmaceutical (BMRN)	$12.4B
Swedish Orphan Biovitrum (BIOVF)	$10.9B
Bio-Techne Corp (TECH)	$10.3B
Vaxcyte (PCVX)	$10.3B
Sarepta Therapeutics (SRPT)	$10.1B
Exelixis (EXEL)	$9.6B
Ascendis Pharma (ASND)	$9.5B
Exact Sciences (EXAS)	$9.2B
QIAGEN (QGEN)	$8.9B
Bio-Rad Laboratories (BIO.B)	$8.7B